Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

被引：5
|
作者：
Shah, Nirali N. [1 ]
Azzi, Jacques [2 ]
Cooper, Brenda W. [3 ]
Deol, Abhinav [4 ]
DiPersio, John [5 ]
Koura, Divya [6 ]
McClune, Brian [7 ]
Muffly, Lori S. [8 ]
Mushtaq, Muhammad Umair [9 ]
Narayan, Rupa [10 ]
Suh, Hyung Chan [11 ]
Yanik, Gregory [12 ]
Nath, Sritama [13 ]
Whangbo, Jennifer [13 ]
Koehne, Guenther [14 ]
机构：
[1] Natl Inst Hlth, Pediat Oncol Branch, Bethesda, MD USA
[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol Cellular Therapy & Bone M, Tisch Canc Inst, New York, NY USA
[3] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[4] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA
[5] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO USA
[6] UCSD Moores Canc Ctr, La Jolla, CA USA
[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[8] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA USA
[9] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Westwood, KS USA
[10] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA
[11] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[12] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[13] Vor Biopharma, Cambridge, MA USA
[14] Miami Canc Inst, Baptist Hlth South Florida, Miami, FL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180990
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] DONOR-DERIVED CLL-1 CHIMERIC ANTIGEN RECEPTOR T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA BRIDGING TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT UPDATE
    Miao, Xiaojuan
    Shuai, Yanrong
    Han, Ying
    Liu, Yilan
    Zhang, Nan
    Yao, Hao
    Wang, Xiao
    He, Guangcui
    Chen, Dan
    Fan, Fangyi
    Chang, Alex H.
    Su, Yi
    Yi, Hai
    BONE MARROW TRANSPLANTATION, 2024, 59 : 219 - 219
  • [2] Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission
    Miao, Xiaojuan
    Shuai, Yanrong
    Han, Ying
    Zhang, Nan
    Liu, Yilan
    Yao, Hao
    Wang, Xiao
    He, Guangcui
    Chen, Dan
    Fan, Fangyi
    Chang, Alex H.
    Su, Yi
    Yi, Hai
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Allogeneic Hematopoietic Stem Cell Transplantation for Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma after Donor-Derived CD7-Chimeric Antigen Receptor T-Cell Therapy
    Li, Zhihui
    Pen, Xiaojuan
    Wen, Xiaopei
    Li, Jing
    Song, Yanzhi
    Xu, Teng
    Wu, Tong
    BLOOD, 2021, 138
  • [4] Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases
    Shelikhova, Larisa
    Rakhteenko, Arina
    Molostova, Olga
    Kurnikova, Elena
    Ukrainskaya, V
    Muzalevsky, Yakov
    Pershin, Dmitry
    Popov, Alexander
    Kulakovskaya, Elena
    Baidildina, Dina
    Stepanov, Alexey
    Osipova, Elena
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2022, 140 : 4600 - 4601
  • [5] Combining Anti-CD33 Chimeric Antigen-Receptor T Cells with the Hypomethylating Agent Decitabine to Treat Acute Myeloid Leukemia
    Ng, Kenneth K. H.
    Del Real, Marissa M.
    Wu, Jonas Jian
    Xue, Tongyuan
    Marcucci, Emanuela
    Yuan, Yate-Ching
    Marcucci, Guido
    Forman, Stephen J.
    Horne, David
    Budde, Lihua E.
    MOLECULAR THERAPY, 2023, 31 (04) : 145 - 146
  • [6] Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation
    Kochenderfer, James N.
    Dudley, Mark E.
    Carpenter, Robert O.
    Kassim, Sadik H.
    Rose, Jeremy J.
    Telford, William
    Hakim, Frances T.
    Halverson, David
    Fowler, Daniel H.
    Hardy, Nancy M.
    Mato, Anthony
    Hickstein, Dennis D.
    Gea-Banacloche, Juan
    Pavletic, Steven Z.
    Sportes, Claude
    Maric, Irma
    Feldman, Steven
    Hansen, Brenna G.
    Wilder, Jennifer
    Blacklock-Schuver, Bazetta
    Jena, Bipulendu
    Bishop, Michael
    Rosenberg, Steven A.
    Gress, Ronald E.
    BLOOD, 2013, 122 (21)
  • [7] Allogeneic Donor-Derived CD19-Chimeric Antigen Receptor (CAR) T Cells for Relapsed B-Cell Malignancies After Hematopoietic Stem Cell Transplantation
    Muhsen, Ibrahim N.
    Cruz, Helton
    Zhang, Huimin
    Thakkar, Sachin G.
    Grilley, Bambi
    Gee, Adrian P.
    Heslop, Helen E.
    Brenner, Malcolm K.
    Ramos, Carlos A.
    MOLECULAR THERAPY, 2022, 30 (04) : 227 - 227
  • [8] ALLOGENEIC DONOR-DERIVED CD19-CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR RELAPSED B-CELL MALIGNANCIES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Muhsen, I. N.
    Cruz, H.
    Zhang, H.
    Thakkar, S. G.
    Grilley, B.
    Gee, A. P.
    Heslop, H.
    Brenner, M.
    Ramos, C. A.
    CYTOTHERAPY, 2022, 24 (05) : S27 - S28
  • [9] Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    卓亚琪
    China Medical Abstracts(Internal Medicine), 2024, 41 (02) : 123
  • [10] Chimeric Antigen Receptor-Modified T Cells for the Treatment of Acute Myeloid Leukemia Expressing CD33
    Song, Degang
    Swartz, Michael H.
    Biesecker, Steve G.
    Borda, Fernando
    Shah, Rutul R.
    Emtage, Peter
    Wierda, William G.
    Cooper, Laurence J. N.
    Chan, Tim
    BLOOD, 2016, 128 (22)
12345